Draper entered a multi-year strategic technology collaboration with Kite, a Gilead Company, to enhance Kite’s development of cell therapies using Draper’s engineering services and portfolio of cell bioprocessing technologies. Draper’s technologies will enable Kite to improve next-generation cell therapies and increase cell manufacturing throughput. Kite will have access to technology and engineering services for developing cancer immunotherapy products with a primary focus on genetically eng...